Cite
HARVARD Citation
Xicoy, B. et al. (n.d.). Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients. Leukemia & lymphoma. 55 (10), pp. 2341-2348. [Online].